Patents by Inventor Nihar R. Pandey

Nihar R. Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF
    Publication number: 20220339150
    Abstract: The present invention relates to the process and therapeutic use of endocannabinoid-targeting novel prodrugs in a delivery system. In particular, the present invention relates to prodrugs of endocannabinoid system-targeting molecules, as cannabidiol (CBD), cannabigerol (CBG), tetrahydrocannabinol (THC), and cannabichromene (CBC) for oral, transmucosal, transdermal, and parenteral administration, and methods and using the same as therapeutics.
    Type: Application
    Filed: April 7, 2022
    Publication date: October 27, 2022
    Inventors: Tapio NEVALAINEN, Rakshit D. KODEKALRA, Jarkko RAUTIO, Mahadev PATIL, Safwat M. RABEA, David Earl BOGUCKI, Nihar R. PANDEY
  • Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product
    Patent number: 11147805
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: October 19, 2021
    Assignee: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253948
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: October 31, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi TIWARI-PANDEY, Rakshit Devappa KODEKALRA, Nihar R. PANDEY
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253947
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey